PE-22-28 5mg

£23.90

PE-22-28 is a specialised research peptide developed for experimental investigation of TREK-1 (K2P2.1) potassium channel inhibition and the structure-activity relationships of spadin-derived peptides.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: 1801959-12-5
  • Molecular Formula: C35H55N11O9

In stock

Add to Cart
OP Labs PE-22-28 5mg research peptide lyophilized powder in glass vial
PE-22-28 5mg
£23.90

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support
  • Guaranteed safe checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides.
  • Batch HPLC tested at ≥ 99% purity.
  • Storage: –20 °C long term; 2–8 °C short term.
  • Sold for research purposes only.

PE-22-28

Synonyms / Designations: PE-22-28, PE 22-28, spadin-derived peptide, sortilin propeptide (22-28) fragment
CAS Number: 1801959-12-5
Molecular Formula: C35H55N11O9
Molecular Weight: ~773.89 g/mol
Peptide Sequence: Gly-Val-Ser-Trp-Gly-Leu-Arg (GVSWGLR)
Peptide Classification: Synthetic peptide corresponding to residues 22-28 of the sortilin propeptide (PE)
Purity: ≥ 99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Pack Size: 5 mg (typical)
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

PE-22-28 is a synthetic seven-residue peptide corresponding to residues 22-28 of the propeptide (PE) released during the maturation of sortilin, a neuronal sorting receptor. It is a shortened form of the 17-residue peptide spadin (PE 12-28) and retains its C-terminal seven residues.

In electrophysiological and cellular research systems, PE-22-28 has been investigated as an inhibitor of the TREK-1 (K2P2.1) two-pore-domain potassium channel, with reported selectivity over the related K2P channels TREK-2, TRAAK, TRESK and TASK-1. Experimental observations depend on model system, channel expression, concentration and exposure duration, and are used to explore channel mechanisms rather than defined physiological outcomes.

Applications in Research

  • Inhibition of TREK-1 (K2P2.1) potassium channel currents in electrophysiology assays
  • Selectivity profiling across two-pore-domain (K2P) potassium channels
  • Comparative studies with spadin and other sortilin propeptide fragments
  • Structure-activity relationship and peptide stability studies

Specifications Summary

Purity: ≥ 99%
Appearance: White to off-white lyophilised powder
Peptide Type: Synthetic sortilin propeptide fragment (PE 22-28)
Molecular Weight: ~773.89 g/mol
Solubility: Water, buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light
Pack Size: 5 mg

Precautions & Notes

  • Experimental behaviour of PE-22-28 is influenced by channel expression and assay conditions
  • Shortened fragments may show activity and selectivity profiles distinct from the parent peptide spadin
  • Buffer composition, pH, and ionic strength may affect peptide stability
  • Appropriate experimental controls are recommended
  • Intended strictly for laboratory research use; not for human or veterinary application

Keywords: PE-22-28, PE 22-28, Spadin-Derived Peptide, Sortilin Propeptide Fragment, TREK-1, K2P Channel, Synthetic Peptide